BIOMAT Database Logo BIOMAT Database Logo

Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. 1995

E L Swart, and R A Mooren, and A C van Loenen
Laboratory Technician, Laboratory of Drug Analysis and Toxicology, Free University Hospital, Amsterdam, Netherlands.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D008140 Lorazepam A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. Apo-Lorazepam,Ativan,Donix,Duralozam,Durazolam,Idalprem,Laubeel,Lorazep Von Ct,Lorazepam Medical,Lorazepam-Neuraxpharm,Lorazepam-Ratiopharm,Novo-Lorazem,Nu-Loraz,Orfidal Wyeth,Sedicepan,Sinestron,Somagerol,Temesta,Tolid,Témesta,WY-4036,Apo Lorazepam,Lorazepam Neuraxpharm,Lorazepam Ratiopharm,Medical, Lorazepam,Novo Lorazem,Nu Loraz,Von Ct, Lorazep,WY 4036,WY4036,Wyeth, Orfidal
D008874 Midazolam A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. Dormicum,Midazolam Hydrochloride,Midazolam Maleate,Ro 21-3981,Versed,Hydrochloride, Midazolam,Maleate, Midazolam,Ro 21 3981,Ro 213981
D011232 Chemical Precipitation The formation of a solid in a solution as a result of a chemical reaction or the aggregation of soluble substances into complexes large enough to fall out of solution. Precipitation, Chemical
D004344 Drug Incompatibility The quality of not being miscible with another given substance without a chemical change. One drug is not of suitable composition to be combined or mixed with another agent or substance. The incompatibility usually results in an undesirable reaction, including chemical alteration or destruction. (Dorland, 27th ed; Stedman, 25th ed) Drug Incompatibilities,Incompatibilities, Drug,Incompatibility, Drug
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D014151 Anti-Anxiety Agents Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. Anti-Anxiety Agent,Anti-Anxiety Drug,Anxiolytic,Anxiolytic Agent,Anxiolytic Agents,Tranquilizing Agents, Minor,Anti-Anxiety Drugs,Anti-Anxiety Effect,Anti-Anxiety Effects,Antianxiety Effect,Antianxiety Effects,Anxiolytic Effect,Anxiolytic Effects,Anxiolytics,Tranquillizing Agents, Minor,Agent, Anti-Anxiety,Agent, Anxiolytic,Agents, Anti-Anxiety,Agents, Anxiolytic,Agents, Minor Tranquilizing,Agents, Minor Tranquillizing,Anti Anxiety Agent,Anti Anxiety Agents,Anti Anxiety Drug,Anti Anxiety Drugs,Anti Anxiety Effect,Anti Anxiety Effects,Drug, Anti-Anxiety,Drugs, Anti-Anxiety,Effect, Anti-Anxiety,Effect, Antianxiety,Effect, Anxiolytic,Effects, Anti-Anxiety,Effects, Antianxiety,Effects, Anxiolytic,Minor Tranquilizing Agents,Minor Tranquillizing Agents

Related Publications

E L Swart, and R A Mooren, and A C van Loenen
Visual compatibility of midazolam hydrochloride with selected drugs during simulated Y-site injection.
November 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
E L Swart, and R A Mooren, and A C van Loenen
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
October 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
E L Swart, and R A Mooren, and A C van Loenen
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
January 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
E L Swart, and R A Mooren, and A C van Loenen
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
December 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
E L Swart, and R A Mooren, and A C van Loenen
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
August 1994, American journal of hospital pharmacy,
E L Swart, and R A Mooren, and A C van Loenen
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration.
January 1999, International journal of pharmaceutical compounding,
E L Swart, and R A Mooren, and A C van Loenen
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
May 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
E L Swart, and R A Mooren, and A C van Loenen
Compatibility of amifostine with selected drugs during simulated Y-site administration.
October 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
E L Swart, and R A Mooren, and A C van Loenen
Physical and chemical stability of palonosetron hydrochloride with Lorazepam and midazolam hydrochloride during simulated y-site administration.
January 2005, International journal of pharmaceutical compounding,
E L Swart, and R A Mooren, and A C van Loenen
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
May 1991, American journal of hospital pharmacy,
Copied contents to your clipboard!